ENTRY       C06909                      Compound
NAME        Cidofovir;
            Cidofovir anhydrous
FORMULA     C8H14N3O6P
EXACT_MASS  279.062
MOL_WEIGHT  279.187
REMARK      ATC code: J05AB12
            Drug group: DG00648
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
                 J05AB12 Cidofovir
                  C06909  Cidofovir
DBLINKS     CAS: 113852-37-2
            PubChem: 9126
            ChEBI: 3696
            NIKKAJI: J407.193J
ATOM        18
            1   N4y N    25.8041  -16.9856
            2   C1b C    25.8172  -18.3343
            3   C8y C    27.0214  -16.2745
            4   C8x C    24.6625  -16.2773
            5   C1c C    24.5999  -19.0453
            6   N5x N    27.0083  -14.9258
            7   O5x O    28.1631  -16.9828
            8   C8x C    24.6493  -14.9286
            9   O2a O    23.3883  -18.3370
            10  C1b C    24.5784  -20.3334
            11  C8y C    25.7967  -14.2175
            12  C1b C    22.2763  -18.9876
            13  N1a N    25.8181  -12.9294
            14  P1b P    21.0647  -18.2792
            15  O1c O    20.2855  -19.6120
            16  O1c O    19.6713  -17.4646
            17  O1c O    21.9147  -16.8252
            18  O1a O    25.7752  -21.0133
BOND        18
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     3   6 1
            6     3   7 2
            7     4   8 2
            8     5   9 1
            9     5  10 1
            10    6  11 2
            11    9  12 1
            12   11  13 1
            13   12  14 1
            14   14  15 1
            15   14  16 1
            16   14  17 2
            17    8  11 1
            18   10  18 1
///
